Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
Clinical trial NCT05027958 · COMPLETED
Trial details
- NCT number
- NCT05027958
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2024-11-07
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.